2BB score and signals
ImmunityBio, Inc.’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 55 | Moderate |
| Momentum | 33 | Weakening |
| Financial strength | 30 | Weak |
| Quality | 97 | Very Strong |
| Risk | 67 | High |
Company facts
| CEO | Rich Adcock |
| Founded | 2014 |
| Employees | 688 |
| 52-week range | $1.95 – $12.43 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-22 | — | -0.0612 | — | $72.56M |
| 2026-11-05 | — | -0.068 | — | $60.44M |
| 2026-08-12 | — | -0.0918 | — | $50.69M |
| 2026-05-07 | -0.08 | -0.0714 | $44.21M | $43.93M |
Related companies
